Clinical outcome of drug-eluting versus bare-metal stents in patients with calcified coronary lesions: A meta-analysis

Internal Medicine Journal

Volumn 45, Issue 2, 2015, Pages 203-211

  Zhang, B C ^a   Wang, C ^a   Li, W H ^a   Li, D Y ^a  

^a XUZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Calcification; Coronary artery disease; Meta analysis; Stent

Indexed keywords

ARTICLE; BARE METAL STENT; BARE METAL STENTING; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; COMPARATIVE EFFECTIVENESS; CORONARY ARTERY CALCIFICATION; CORONARY STENTING; DRUG ELUTING CORONARY STENT; FOLLOW UP; HEART DEATH; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; INTERMETHOD COMPARISON; META ANALYSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENT DISEASE; RETROSPECTIVE STUDY; SENSITIVITY ANALYSIS; STENT THROMBOSIS; SYSTEMATIC REVIEW;

EID: 84964267885     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/imj.12622     Document Type: Article

References (21)

1. Ellis SG, Guetta V, Miller D, Whitlow PL, Topol EJ. Relation between lesion characteristics and risk with percutaneous intervention in the stent and glycoprotein IIb/IIIa era: an analysis of results from 10907 lesions and proposal for new classification scheme. Circulation 1999; 100: 1971-1976.
2. Moussa I, Di Mario C, Moses J, Reimers B, Di Francesco L, Martini G etal. Coronary stenting after rotational atherectomy in calcified and complex lesions. Angiographic and clinical follow-up results. Circulation 1997; 96: 128-136.
3. Tomey MI, Kini AS, Sharma SK. Current status of rotational atherectomy. JACC Cardiovasc Interv 2014; 7: 345-353.
4. Stone GW, Ellis SG, Cannon L, Mann JT, Greenberg JD, Spriggs D etal. Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial. JAMA 2005; 294: 1215-1223.
5. Bangalore S, Kumar S, Fusaro M, Amoroso N, Attubato MJ, Feit F etal. Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials. Circulation 2012; 125: 2873-2891.
6. Thompson SG, Sharp SJ. Explaining heterogeneity in meta-analysis: a comparison of methods. Stat Med 1999; 18: 2693-2708.
7. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP etal. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med 2009; 151: W65-94.
8. Moussa I, Ellis SG, Jones M, Kereiakes DJ, McMartin D, Rutherford B etal. Impact of coronary culprit lesion calcium in patients undergoing paclitaxel-eluting stent implantation (a TAXUS-IV sub study). Am J Cardiol 2005; 96: 1242-1247.
9. Seo A, Fujii T, Inoue T, Onoda S, Koga A, Tanaka Y etal. Initial and long-term outcomes of sirolimus-eluting stents for calcified lesions compared with bare-metal stents. Int Heart J 2007; 48: 137-147.
10. Khattab AA, Otto A, Hochadel M, Toelg R, Geist V, Richardt G. Drug-eluting stents versus bare metal stents following rotational atherectomy for heavily calcified coronary lesions: late angiographic and clinical follow-up results. J Interv Cardiol 2007; 20: 100-106.
11. Rathore S, Matsuo H, Terashima M, Kinoshita Y, Kimura M, Tsuchikane E etal. Rotational atherectomy for fibro-calcific coronary artery disease in drug eluting stent era: procedural outcomes and angiographic follow-up results. Catheter Cardiovasc Interv 2010; 75: 919-927.
12. Bangalore S, Vlachos HA, Selzer F, Wilensky RL, Kip KE, Williams DO etal. Percutaneous coronary intervention of moderate to severe calcified coronary lesions: insights from the National Heart, Lung, and Blood Institute Dynamic Registry. Catheter Cardiovasc Interv 2011; 77: 22-28.
13. Auer J, Leitner A, Berent R, Lamm G, Lassnig E, Krennmair G. Long-term outcomes following coronary drug-eluting- and bare-metal-stent implantation. Atherosclerosis 2010; 210: 503-509.
14. Nakazawa G. Stent thrombosis of drug eluting stent: pathological perspective. J Cardiol 2011; 58: 84-91.
15. Onuma Y, Tanimoto S, Ruygrok P, Neuzner J, Piek JJ, Seth A etal. Efficacy of everolimus eluting stent implantation in patients with calcified coronary culprit lesions: two-year angiographic and three-year clinical results from the SPIRIT II study. Catheter Cardiovasc Interv 2010; 76: 634-642.
16. Furuichi S, Sangiorgi GM, Godino C, Airoldi F, Montorfano M, Chieffo A etal. Rotational atherectomy followed by drug-eluting stent implantation in calcified coronary lesions. EuroIntervention 2009; 5: 370-374.
17. García de Lara J, Pinar E, Gimeno JR, Antonio Hurtado J, Lacunza J, Valdesuso R etal. Percutaneous coronary intervention in heavily calcified lesions using rotational atherectomy and Paclitaxel-eluting stents: outcomes at one year. Rev Esp Cardiol 2010; 63: 107-110.
18. Rathore S, Matsuo H, Terashima M, Kinoshita Y, Kimura M, Tsuchikane E etal. Rotational atherectomy for fibro-calcific coronary artery disease in drug eluting stent era: procedural outcomes and angiographic follow-up results. Catheter Cardiovasc Interv 2010; 75: 919-927.
19. Pfisterer M, Brunner-La Rocca HP, Buser PT, Rickenbacher P, Hunziker P, Mueller C etal. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents. J Am Coll Cardiol 2006; 48: 2584-2591.
20. Piscione F, Piccolo R, Cassese S, Galasso G, De Rosa R, D'Andrea C etal. Effect of drug-eluting stents in patients with acute ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: a meta-analysis of randomised trials and an adjusted indirect comparison. EuroIntervention 2010; 5: 853-860.
21. De Luca G, Dirksen MT, Spaulding C, Kelbaek H, Schalij M, Thuesen L etal. Meta-analysis comparing efficacy and safety of first generation drug-eluting stents to bare-metal stents in patients with diabetes mellitus undergoing primary percutaneous coronary intervention. Am J Cardiol 2013; 111: 1295-1304.